Saturday 5 April 2003
Organizer A. Semplicini (Padova, Italy)
Sponsors Neopharmed
Merck, Sharp & Dohme

Cerebrovascular complications of hypertension: actual and future developments

Session I
Chairs A.C. Pessina (Padova, Italy) & A. Lechi (Verona, Italy) Abstract No.
14.00 – 14.10 Welcome and introduction: hard versus soft cerebrovascular end points in clinical trials
A. Semplicini (Padova, Italy)
14.10 – 14.30 Hypertension and stroke: epidemiology and prevention
C. Cuspidi (Milan, Italy)
14.30 – 14.50 Hypertension and stroke: epidemiology and prevention
G. Leonetti (Milan, Italy)
Session II Round table
Chairs P. Amodio (Padova, Italy) & G. Meneghetti (Padova, Italy)
14.50 – 15.10 Neuropsychological testing in the early detection of cognitive dysfuntion in hypertension
C.A. Umiltà (Padova, Italy)
15.10 – 15.30 US studies in the evaluation of the risk of developing vascular dementia
N. Bornstein (Tel-Aviv, Israel)
15.30 – 15.50 Biochemical markers of cerebral ischaemia
P. Madeddu and C. Emanueli (Sassari, Italy)
15.50 – 16.10 PET / SPET in the assessment of cerebral perfusion and metabolism
A. Cagnin (Padova, Italy)
16.10 – 16.20 coffee break
16.20 – 16.40 The neurophysiological tools in the assessment of early mental changes associated to severe hypertension
G. Barrett (Fareham, UK)
16.40 – 17.00 Neuroimaging
P. Scheltens (Amsterdam, The Netherlands)
17.00 – 17.30 Discussion
17.30 – 17.45 Cognitive decline and diabetes type 1
F. Del Piccolo, D. Mapelli, A. Maran, C. Crepaldi, P. Amodio,and C. Umiltà (Padova, Italy)
17.45 – 18.00 Impaired cerebral vasoreactivity in hypertensives: an early marker of vascular dementia?
A. Realdi, V. Mascagna, L. Ciccariello, L. Macchini, F. Del Piccolo, P. Amodio, D. Mapelli, A.M. Maresca, and A. Semplicini (Padua, Italy)
18.00 End of workshop